FDA-Cleared Artificial Intelligence Breast Cancer Diagnosis System Launched By Paragon Biosciences

Product will help provide a more accurate diagnosis for breast cancer patients, stemming from three decades of research at the University of Chicago.

Sourced through Scoop.it from: www.mpo-mag.com